$IMRA

Imara Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$1.16 ▼-1.695%

Last Close

VOLUME

41,389

DAY RANGE

1.1396 - 1.21

52 WEEK

0.9739 - 7.88

Key Metrics

Market Cap

31.01 M

Beta

0.66

Avg. Volume

71.91 K

Shares Outstanding

26.28 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-05

Next Dividend Date

Company Information

Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.

Website:

HQ: ,

Related News